Brief: Xintela Broadens And Extends Patent Protection For Chondrocyte Products
08/01/2019 07:33
Jan 8 (Reuters) - Xintela AB XINT.ST :
* XINTELA BROADENS AND EXTENDS PATENT PROTECTION FOR CHONDROCYTE PRODUCTS AND CHONDROCYTE
MARKERS
Source text for Eikon: ID:nBQNbyfZr2
Further company coverage: XINT.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Xintela AB
See all newsBrief: Xintela To Raise SEK 30 Mln Via Convertible Loan From Flerie Invest
Advisory: Alerts on Xintela's phase I/IIa XSTEM results withdrawn
Brief: Xintela Q1 2026 Loss Before Tax SEK 11.8 Mln
Brief: Xintela Study Finds XSTEM Treatment Safe, Well Tolerated
Brief: Xintela Gets U.S. Patent For Xstem Treatment Of Difficult-To-Heal Wounds, Skin Defects